EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma

Mahdieh Hamidfar, Elnaz Sheikhpour, Mahmood Akhavan Tafti, Fateme Daneshmand, Mehdi Abedinzadeh

Iranian Journal of Blood and Cancer · 2022

DOI: 10.58209/ijbc.14.3.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Mahdieh Hamidfar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hamidfar, M., Sheikhpour, E., Tafti, M. A., Daneshmand, F., & Abedinzadeh, M. (2022). Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.3.11

Vancouver

Hamidfar M, Sheikhpour E, Tafti MA, Daneshmand F, Abedinzadeh M. Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.3.11

BibTeX
@article{Hamidfar2022,
  author = {Hamidfar, Mahdieh and Sheikhpour, Elnaz and Tafti, Mahmood Akhavan and Daneshmand, Fateme and Abedinzadeh, Mehdi},
  title = {Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma},
  journal = {Iranian Journal of Blood and Cancer},
  year = {2022},
  doi = {10.58209/ijbc.14.3.11}
}
Kostenlos starten →